InvestorsHub Logo
icon url

Lottalead

08/02/21 9:07 PM

#5883 RE: Cbrnlol #5881

The ties binding together the Aingura/ IIOT-OXYS partnership are strong. Both CEO’s have expressed this in press releases.

Mr. Ibeas stated, “IIOT-OXYS, Inc.’s successful pilots in Pharma Operations, and Structural Health Monitoring, and their extensive U.S. prospects make them a strong partner”. Mr. Emmons concluded, “In combining our efforts, we’ve been able to build upon our successful pilots and installations to expand our algorithms and insights and create foundational case studies. Rafael and I expect this marketing collateral, in conjunction with our prospecting efforts, will lead to new business in due time.”

https://www.otcmarkets.com/filing/html?id=15045079&guid=UkX1kKC9-Dp8_yh


Our prospecting efforts have advanced several companies under NDA to the proposal stage. The proposals pending are with a combination of prospects developed by both IIOT-OXYS, Inc. and Aingura IIoT, S.L. Together, we are pursuing additional proposals and non-dilutive grants. We have also brought on a marketing firm to update the IIOT-OXYS, Inc. website & generate sales leads.

https://www.otcmarkets.com/filing/html?id=15061312&guid=UkX1kKC9-Dp8_yh

I and Chandran, in his role as Advisory Board Chairman, will continue building a strong technical relationship with our previously disclosed collaboration partner, Aingura IIoT, S.L. This collaboration, along with the previously disclosed completion of successful pilots with a Fortune 500 Pharma company, and New England state’s DOT have allowed the Company and its partner to prepare use cases in smart manufacturing and bridge structural health monitoring respectively, allowing us to renew engagements with all of the Company's earlier prospects and reach out to new ones.

https://www.otcmarkets.com/filing/html?id=15080690&guid=UkX1kKC9-Dp8_yh

That little tidbit of information in bold tells us that the Fortune 500 Pharma company AND the New England state’s DOT both RENEWED THEIR CONTRACTS.
Totally and completely overlooked by the masses for weeks.

“We are expanding into ‘discrete manufacturing’ processes applicable to medical devices, building on our successes with ‘continuous manufacturing’ processes characteristic to biotech and pharmaceutical production

The successes are with the Fortune 500 Pharma company that resigned, IMO.

https://www.otcmarkets.com/filing/html?id=15088062&guid=UkX1kKC9-Dp8_yh

This marks the third such agreement with a structural health monitoring focused organization, for a total of six new NDAs in our SHM and smart manufacturing sectors this year. We are excited the leader of this company saw our successful New England DOT Bridge Monitoring Pilot completed in the late summer of 2020 and our ability to attract top academic institutions focused on SHM to partner with us, as complementary to their technology and successful proof of concept on their railway bridge infrastructure project. This partnership will include exploring possible acquisition of the company or purchase of its assets. Together with this company and our strong collaboration with Aingura IIoT, S.L. we are positioned to pursue contracts in SHM worldwide.

https://www.otcmarkets.com/filing/html?id=15088062&guid=UkX1kKC9-Dp8_yh

The partnership has so far PROVEN to be a great success. The number of NDA’s has risen dramatically, the stock price will soon follow. IMO